Showing papers by "José Luis Sánchez-Quesada published in 2016"

TL;DR: It was found that NF-kB, AP-1 and CREB inhibitors decreased LDL(-)-induced cytokine release, mainly on MCP1, IL6 and IL10 release, respectively.

TL;DR: The initial rapid aggregation of LDL(-) is apparently counterbalanced by the stabilizing effects of minor proteins such as apoA-I and apoJ, which help identify key determinants for LDL aggregation, fusion and coalescence into lipid droplets in vivo.